Finally, we established a xenograft model and confirmed that the overexpression of FAM99A inhibits HCC tumor growth, downregulates GLUT1, and blocks nuclear translocation of STAT3 in vivo. This evidence concerns the gene SLC2A1 and hepatocellular carcinoma.